These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8735204)

  • 41. Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.
    Vermeulen A; Piotrovsky V; Ludwig EA
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):183-206. PubMed ID: 17136449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics.
    Pollak PT; Verjee ZH; Lyon AW
    J Clin Pharmacol; 2011 Jul; 51(7):1112-5. PubMed ID: 20663990
    [No Abstract]   [Full Text] [Related]  

  • 43. Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry.
    Flarakos J; Luo W; Aman M; Svinarov D; Gerber N; Vouros P
    J Chromatogr A; 2004 Feb; 1026(1-2):175-83. PubMed ID: 14763744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MultiSimplex optimization of chromatographic separation and dansyl derivatization conditions in the ultra performance liquid chromatography-tandem mass spectrometry analysis of risperidone, 9-hydroxyrisperidone, monoamine and amino acid neurotransmitters in human urine.
    Cai HL; Zhu RH; Li HD; Zhang J; Li LF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1993-9. PubMed ID: 21621490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry.
    Aravagiri M; Marder SR
    J Mass Spectrom; 2000 Jun; 35(6):718-24. PubMed ID: 10862124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olanzapine-related fatality.
    Stephens BG; Coleman DE; Baselt RC
    J Forensic Sci; 1998 Nov; 43(6):1252-3. PubMed ID: 9846408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
    Titier K; Déridet E; Moore N
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):145-9. PubMed ID: 11969382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risperidone in schizophrenia: is there a role for therapeutic drug monitoring?
    Seto K; Dumontet J; Ensom MH
    Ther Drug Monit; 2011 Jun; 33(3):275-83. PubMed ID: 21436762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of age and gender on risperidone plasma concentrations.
    Aichhorn W; Weiss U; Marksteiner J; Kemmler G; Walch T; Zernig G; Stelzig-Schoeler R; Stuppaeck C; Geretsegger C
    J Psychopharmacol; 2005 Jul; 19(4):395-401. PubMed ID: 15982995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cyamemazine on the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: a preliminary retrospective study.
    Lancelin F; Bourcier E; Le Masson V; Lemeille Y; Brovedani S; Paubel P; Piketty ML
    Ther Drug Monit; 2010 Dec; 32(6):757-61. PubMed ID: 21068648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection.
    Locatelli I; Mrhar A; Grabnar I
    J Pharm Biomed Anal; 2009 Dec; 50(5):905-10. PubMed ID: 19589654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
    Aman MG; Vinks AA; Remmerie B; Mannaert E; Ramadan Y; Masty J; Lindsay RL; Malone K
    Clin Ther; 2007 Jul; 29(7):1476-86. PubMed ID: 17825699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
    Meltzer HY; Lindenmayer JP; Kwentus J; Share DB; Johnson R; Jayathilake K
    Schizophr Res; 2014 Apr; 154(1-3):14-22. PubMed ID: 24630262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal overdoses associated with quetiapine.
    Langman LJ; Kaliciak HA; Carlyle S
    J Anal Toxicol; 2004 Sep; 28(6):520-5. PubMed ID: 15516308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand.
    Boonleang J; Pipatrattanaseree W; Tanthana C; Mahatthanatrakul W
    Clin Ther; 2010 Sep; 32(10):1842-53. PubMed ID: 21194608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute risperidone overdose.
    Catalano G; Catalano MC; Taylor W
    Clin Neuropharmacol; 1997 Feb; 20(1):82-5. PubMed ID: 9037577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia.
    Suzuki H; Gen K; Otomo M; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K
    Hum Psychopharmacol; 2014 May; 29(3):244-50. PubMed ID: 24911575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice.
    Kirschbaum KM; Henken S; Hiemke C; Schmitt U
    Behav Brain Res; 2008 Apr; 188(2):298-303. PubMed ID: 18164477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed respiratory depression after risperidone overdose.
    Akyol A; Senel AC; Ulusoy H; Karip F; Erciyes N
    Anesth Analg; 2005 Nov; 101(5):1490-1491. PubMed ID: 16244016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical antipsychotic overdose in the pediatric population.
    Catalano G; Catalano MC; Nunez CY; Walker SC
    J Child Adolesc Psychopharmacol; 2001; 11(4):425-34. PubMed ID: 11838825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.